top of page


Consider the different. Controlled substances are in the forefront of addiction and the law, the medical effects and benefits are overshadowed.

1) Cannabis.

Cannabis and cannabinoids are being studied for their potential to alleviate cancer-related symptoms (such as nausea and pain) and for direct anti-tumor effects. While some preclinical studies suggest cannabinoids may inhibit tumor growth, clinical evidence remains limited. Researchers are delving into how cannabis affects the brain, with studies examining its impact on cognitive functions, brain structure, and neural activity. There's a growing interest in understanding how age and frequency of use influence these effects.

2) MDMA.

Phase 3 clinical trials have shown MDMA-assisted psychotherapy to be effective in treating post-traumatic stress disorder (PTSD). The U.S. Food and Drug Administration (FDA) has granted MDMA "breakthrough therapy" designation, accelerating the development and review process for drugs that show substantial improvement over existing treatments. 

3) LSD, Psilocybin and Others.

Clinical trials have demonstrated that psilocybin therapy can produce rapid and sustained antidepressant effects in individuals with treatment-resistant depression. The therapy involves supervised administration of psilocybin in a controlled setting, accompanied by psychological support. LSD is being investigated for its ability to alleviate anxiety, particularly in life-threatening conditions such as terminal illnesses. Early studies indicate that LSD, in conjunction with psychotherapy, may help reduce anxiety associated with the fear of death in cancer patients.

4) Neuroplasticity and Brain Connectivity.


Research using functional MRI (fMRI) has revealed that psychedelics like LSD and psilocybin can increase neural plasticity and enhance connectivity across different regions of the brain. These changes are thought to underlie the therapeutic effects of psychedelics, including increased openness and the ability to break free from destructive patterns of thought and behavior.

5) Integration of Traditional Medicine.

There is an increasing acknowledgment of the traditional use of psychedelics in indigenous cultures for spiritual and healing purposes. Researchers and therapists are exploring ways to integrate this traditional knowledge with Western therapeutic practices.

As the field advances, ethical and regulatory considerations are paramount, including ensuring informed consent, addressing the risks of psychedelics, and developing standards for therapist training and psychedelic-assisted therapy practices. The promising results from recent research have the potential to lead to the approval of psychedelic substances for therapeutic use, marking a significant shift in the treatment of mental health disorders.

MRI Scan Image
bottom of page